Word

ORIYA

Status

Dead

Status Code

602

Status Date

Saturday, March 16, 2019

Serial Number

87648361

Mark Type

4000

Filing Date

Tuesday, October 17, 2017

Abandoned Date

Tuesday, February 19, 2019

Trademark Owner History

Teva Pharmaceuticals USA, Inc.

Classifications

5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Trademark Events

Mar 18, 2019

Abandonment Notice E-Mailed - Failure To Respond

Mar 16, 2019

Abandonment - Failure To Respond Or Late Response

Aug 22, 2018

Undeliverable Mail - Courtesy Copy Mailed

Aug 18, 2018

Notification Of Final Refusal Emailed

Aug 18, 2018

Final Refusal E-Mailed

Aug 18, 2018

Final Refusal Written

Jul 26, 2018

Teas/Email Correspondence Entered

Jul 26, 2018

Correspondence Received In Law Office

Jul 26, 2018

Teas Response To Office Action Received

Jan 29, 2018

Notification Of Non-Final Action E-Mailed

Jan 29, 2018

Non-Final Action E-Mailed

Jan 29, 2018

Non-Final Action Written

Jan 22, 2018

Assigned To Examiner

Oct 26, 2017

New Application Office Supplied Data Entered In Tram

Oct 20, 2017

New Application Entered In Tram